A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/10/2002	US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002	US20020146820 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
10/10/2002	US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002	US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002	US20020146686 Detecting nucleotide sequences asociated with preferential viral disease; obtain nuclotide sequence sample, incubate with probes, detect signal, presence of signal indicates viral nucleotide sequences
10/10/2002	US20020146683 Modified hiv env polypeptides
10/10/2002	US20020146473 High temperature solvent extraction of echinacea plant extracts; drying to form powders, then compressing with excipients to form tablets; efficiency
10/10/2002	US20020146448 B-glucans encapsulated in liposomes
10/10/2002	US20020146435 In ovo vaccination against coccidiosis
10/10/2002	US20020146434 As vaccine or gene vaccine; diagnostic reagent capable of accurately detecting infections with an epidemic strain of measles virus
10/10/2002	US20020146431 For prophylaxis of porcine multisystemic wasting syndrome (PMWS)
10/10/2002	US20020146430 Use of ClyA hemolysin for excretion of proteins
10/10/2002	US20020146426 Administering molecule joined to a heat shock protein or molecule joined to an adenosinetriphosphate (ATP) binding domain of a heat shock protein inducing an immune response that includes a CD8+ cytotoxic T lymphocyte (CTL) response
10/10/2002	US20020146423 Protective helicobacter antigens
10/10/2002	US20020146397 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
10/10/2002	US20020146396 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
10/10/2002	US20020146390 Therapy of sepsis and adult respiratory distress syndrome using chemokine or biologically active fragment thereof, alone or in conjunction with an anti-infective agent
10/10/2002	DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002	DE10115310A1 Bakteriophagen-Präparation Bacteriophage preparation
10/10/2002	DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002	DE10114247A1 Antibiotikum-/Antibiotika-Polymer-Kombination Antibiotic / polymer combination
10/10/2002	CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002	CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002	CA2442149A1 Viral vectors
10/10/2002	CA2442064A1 G-protein coupled receptors
10/10/2002	CA2442062A1 Secreted proteins
10/10/2002	CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002	CA2441778A1 Aminopiperidine derivatives as modulators of chemokine receptor activity
10/10/2002	CA2441654A1 Cytoskeleton-associated proteins
10/10/2002	CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002	CA2441252A1 Estrogen replacement therapy
10/10/2002	CA2441084A1 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002	CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002	CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	CA2437789A1 Topical composition comprising an antifungal
10/10/2002	CA2435390A1 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002	CA2433910A1 Antibiotics from bacteria isolated from amphibian skin
10/09/2002	WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002	EP1247865A2 Antibody for use in therapy
10/09/2002	EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002	EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002	EP1247099A2 Methods and compositions for detecting hepatitis e virus
10/09/2002	EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002	EP1246929A2 Methods and compositions for obtaining disease protection for animals
10/09/2002	EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002	EP1246912A2 Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002	EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002	EP1246838A1 Lipopeptides as antibacterial agents
10/09/2002	EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
10/09/2002	EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002	EP1246810A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
10/09/2002	EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002	EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002	EP1246804A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor
10/09/2002	EP1246795A2 Antibacterial agents
10/09/2002	EP1246692A1 Templating of solid particles by polymer multilayers
10/09/2002	EP1246648A2 Dendrimer-photosensitizer complexes for medical applications
10/09/2002	EP1246647A1 Non-immunosuppressant hiv tat
10/09/2002	EP1246644A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
10/09/2002	EP1246641A2 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
10/09/2002	EP1246640A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
10/09/2002	EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002	EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002	EP1246628A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/09/2002	EP1246627A2 Polyanhydrides with biologically active degradation products
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002	EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002	EP1246538A1 Thickened oil compositions of edible oil
10/09/2002	EP1133495B1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
10/09/2002	EP1129208B1 Vancoresmycin, a process for its production and its use as a pharmaceutical
10/09/2002	EP1049467B1 Celecoxib compositions
10/09/2002	EP1039909B1 Method of production and composition of an oral preparation of itraconazole
10/09/2002	EP0964856B1 Bicyclic amino acids
10/09/2002	EP0931088B1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs
10/09/2002	EP0880360B1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
10/09/2002	EP0693934B1 Methods and compositions for the prevention or treatment of sexually transmitted diseases
10/09/2002	EP0640098B1 Canine coronavirus s gene and uses therefor
10/09/2002	CN1373805A Antigenic meningococcal peptides
10/09/2002	CN1373801A Glucuronoxylomannan (GXM)-O-acetylhydrolase of cryptococcus neoformans and uses thereof
10/09/2002	CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002	CN1373771A Vaccine
10/09/2002	CN1373770A Pseudomycin prodrugs
10/09/2002	CN1373768A Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
10/09/2002	CN1373767A Ketolide antibacterials
10/09/2002	CN1373763A Pteridinones and kinase inhibitors
10/09/2002	CN1373754A Antibacterial agents
10/09/2002	CN1373669A Hybrid polypeptides with enhanced pharmacokinetic properties
10/09/2002	CN1373668A Hybrid peptide modulate immune response
10/09/2002	CN1373664A Therapeutic method
10/09/2002	CN1373663A Use of 2-imidazolyl substd, carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions
10/09/2002	CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002	CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002	CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002	CN1372974A Exterior-applied gel contaiing lysozyme as primary component and its preparing process
10/09/2002	CN1372967A Umbilical patch for treating cold
10/09/2002	CN1372965A Garlic extract capsule and its preparing process
10/09/2002	CN1372956A Medicine for treating pulmonary tuberculosis and its preparing process

1 ... 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 ... 1798